Skip to main content
. 2023 Jan 9;13:419. doi: 10.1038/s41598-022-27090-1

Figure 3.

Figure 3

Cisplatin-treated PGCC-enriched cells have a distinct metabolic profile. The metabolome of cisplatin-treated (orange peaks) and untreated bladder cancer cells (gray peaks) were assessed by gas chromatography-mass spectrometry (GC–MS).